- 中文别名:五氧化二钒
- 中文释义:五氧化二钒;矾酸酐;钒(酸)酐;五氧化二矾;氧化矾;氧化钒;无水钒酸;五氧化钒;氧化钒(V);Phosphoric Pentoxide;tricyclo[3.3.1.1~3,7~]tetraphosphoxane 1,3,5,7-tetraoxide;1,3-dioxodiphosphoxane-1,3-diium-1,3-diolate;Phosphorus(Ⅴ)oxide;Phosphorous Pentoxide (P2O5);Phosphorus pentoxide;actox216;a
- 英文别名:divanadium pentaoxide;
vanadium dichloride;
Divanadium pentaoxide Divanadium pentoxide Pentaoxodivanadium Vandia;
Vanadium pentoxide;
Divanadium pentaoxide Divanadium pentoxide Pentaoxodivanadium Vandia vanadium - cas No.:1314-62-1
- 分子式:
O5V2
- 分子量:181.88000
- 精确分子量:181.86200
- PSA:77.51000
- MDL:MFCD00011457
- InChI:InChI=1/5O.2V/rO5V2/c1-6(2)5-7(3)4
- 分子结构式:
物化性质
- 外观与性状:
- 黄色至生锈-棕色片状
- 密度:
- 3.357
- 熔点:
- 690ºC
- 沸点:
- 1750ºC
- 闪点:
- 1750ºC
- 水溶解性:
- 1 g/125 mL
- 存储条件/存储方法:
- 库房通风低温干燥,与酸类,食品分开储运
- 稳定性相关:
1.五氧化二钒蒸气有毒!难溶于水,但生成钒酸,使溶液显酸性。此外,虽然难溶于硫酸和硝酸,但可溶于碱性水溶液。
2.可溶于盐酸并放出氯气,被还原成Ⅳ+氧化态。
- 其它信息:
1. 性状:橙黄色结晶性粉末或红棕色针状结晶粉末。
2. 密度(g/mL,25/4℃): 3.357
3. 相对蒸汽密度(g/mL,空气=1):未确定
4. 熔点(ºC):690
5. 沸点(ºC,常压):1750
6. 沸点(ºC,5.2kPa): 未确定
7. 折射率: 未确定
8. 闪点(ºC): 未确定
9. 比旋光度(º): 未确定
10. 自燃点或引燃温度(ºC): 未确定
11. 蒸气压(kPa,25ºC): 未确定
12. 饱和蒸气压(kPa,60ºC): 未确定
13. 燃烧热(KJ/mol):未确定
14. 临界温度(ºC): 未确定
15. 临界压力(KPa): 未确定
16. 油水(辛醇/水)分配系数的对数值: 未确定
17. 爆炸上限(%,V/V):未确定
18. 爆炸下限(%,V/V): 未确定
19. 溶解性:溶于浓酸、碱,微溶于水,不溶于无水乙醇。
安全信息
- 外观与性状:
- 黄色至生锈-棕色片状
- 密度:
- 3.357
- 熔点:
- 690ºC
- 沸点:
- 1750ºC
- 闪点:
- 1750ºC
- 水溶解性:
- 1 g/125 mL
- 存储条件/存储方法:
- 库房通风低温干燥,与酸类,食品分开储运
- 稳定性相关:
1.五氧化二钒蒸气有毒!难溶于水,但生成钒酸,使溶液显酸性。此外,虽然难溶于硫酸和硝酸,但可溶于碱性水溶液。
2.可溶于盐酸并放出氯气,被还原成Ⅳ+氧化态。
- 其它信息:
1. 性状:橙黄色结晶性粉末或红棕色针状结晶粉末。
2. 密度(g/mL,25/4℃): 3.357
3. 相对蒸汽密度(g/mL,空气=1):未确定
4. 熔点(ºC):690
5. 沸点(ºC,常压):1750
6. 沸点(ºC,5.2kPa): 未确定
7. 折射率: 未确定
8. 闪点(ºC): 未确定
9. 比旋光度(º): 未确定
10. 自燃点或引燃温度(ºC): 未确定
11. 蒸气压(kPa,25ºC): 未确定
12. 饱和蒸气压(kPa,60ºC): 未确定
13. 燃烧热(KJ/mol):未确定
14. 临界温度(ºC): 未确定
15. 临界压力(KPa): 未确定
16. 油水(辛醇/水)分配系数的对数值: 未确定
17. 爆炸上限(%,V/V):未确定
18. 爆炸下限(%,V/V): 未确定
19. 溶解性:溶于浓酸、碱,微溶于水,不溶于无水乙醇。
毒理性
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- YW2450000
- CHEMICAL NAME :
- Vanadium pentoxide (dust)
- CAS REGISTRY NUMBER :
- 1314-62-1
- LAST UPDATED :
- 199806
- DATA ITEMS CITED :
- 55
- MOLECULAR FORMULA :
- O5-V2
- MOLECULAR WEIGHT :
- 181.88
- WISWESSER LINE NOTATION :
- VA2 O5
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration into the eye
- SPECIES OBSERVED :
- Rodent - rabbit
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Human
- DOSE/DURATION :
- 346 mg/m3
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - cough Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - sputum
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Human
- DOSE/DURATION :
- 1 mg/m3/8H
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - cough Lungs, Thorax, or Respiration - bronchiolar constriction Sense Organs and Special Senses (Eye) - conjunctive irritation
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 10 mg/kg
- TOXIC EFFECTS :
- Behavioral - coma
- TYPE OF TEST :
- LC50 - Lethal concentration, 50 percent kill
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 126 mg/m3/6H
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - ataxia Lungs, Thorax, or Respiration - dyspnea
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 12 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 14 mg/kg
- TOXIC EFFECTS :
- Behavioral - coma
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intratracheal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 6 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 5 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 23 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 10 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LCLo - Lowest published lethal concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Mammal - cat
- DOSE/DURATION :
- 500 mg/m3/23M
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 50 mg/kg
- TOXIC EFFECTS :
- Liver - other changes Kidney, Ureter, Bladder - other changes
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 20 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 91 mg/kg/26W-I
- TOXIC EFFECTS :
- Behavioral - alteration of operant conditioning
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1280 mg/kg/15W-C
- TOXIC EFFECTS :
- Blood - pigmented or nucleated red blood cells Blood - changes in erythrocyte (RBC) count Skin and Appendages - hair
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 100 ug/m3/24H/24D-C
- TOXIC EFFECTS :
- Brain and Coverings - recordings from specific areas of CNS Nutritional and Gross Metabolic - weight loss or decreased weight gain Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 2 mg/m3/1H/13W-I
- TOXIC EFFECTS :
- Behavioral - alteration of classical conditioning
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 56 mg/kg/14D-I
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - other changes Biochemical - Metabolism (Intermediary) - lipids including transport
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intratracheal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 7200 ug/kg/1Y-I
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - other changes Lungs, Thorax, or Respiration - changes in lung weight Biochemical - Metabolism (Intermediary) - amino acids (including renal excretion)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 90 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetal death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 180 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - other effects to embryo
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 10 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 10 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 50 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - skin and skin appendages Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 5 mg/kg
- SEX/DURATION :
- female 10 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - skin and skin appendages Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 85 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 85 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - other effects to embryo
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 170 mg/kg
- SEX/DURATION :
- male 60 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 170 mg/kg
- SEX/DURATION :
- male 60 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count) Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intravenous
- DOSE :
- 10900 mg/kg
- SEX/DURATION :
- female 8 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - musculoskeletal system
MUTATION DATA
- TYPE OF TEST :
- Micronucleus test
- TEST SYSTEM :
- Rodent - hamster Lung
- REFERENCE :
- MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 321,35,1994 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 0.05 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 TOXICOLOGY REVIEW FRMBAZ Farmacia (Bucharest). (Rompresfilatelia, POB 12-201, Bucharest, Romania) V.1- 1953- Volume(issue)/page/year: 21,325,1973 TOXICOLOGY REVIEW 85DHAX "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Volume(issue)/page/year: V,46,1974 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:CL 0.5 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,275,1971 OSHA PEL (Gen Indu):CL 0.5 mg(V2O5)/m3, respirable dust CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):CL 0.5 mg(V2O5)/m3, respirable fraction CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):CL 0.5 mg(V2O5)/m3, respirable fraction CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):CL 0.5 mg(V2O5)/m3, respirable fraction CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO VANADIUM (as V2O5), resp dust/fume-air:CL 0.05 mg/m3/15MREFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 76210 No. of Facilities: 333 (estimated) No. of Industries: 7 No. of Occupations: 12 No. of Employees: 2562 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 76210 No. of Facilities: 67 (estimated) No. of Industries: 6 No. of Occupations: 17 No. of Employees: 4468 (estimated) No. of Female Employees: 541 (estimated)
- 毒理学数据:
急性毒性:小鼠口经LD50:5mg/kg;大鼠口经LD50:10mg/kg;小兔皮层组织LD50:50mg/kg;大鼠吸入LC50:126mg/m3/6H
对呼吸系统和皮肤有损害作用。
- 生态数据:
水危害级别3:对水是极其危害的,即使是少量产品渗入地下也会对饮用水造成危害,若无政府许可勿将产品排入周围环境。对水中有机物有剧毒和危害
MSDS
第一部分:化学品名称 |
化学品中文名称: | 五氧化二钒;钒酸酐 |
化学品英文名称: | Vanadium pentoxide |
中文俗名或商品名: | |
Synonyms: | |
CAS No.: | 1314-62-1 |
分子式: | V2O5 |
分子量: | 182 |
第二部分:成分/组成信息 |
纯化学品 混合物 | ||||||
化学品名称:五氧化二钒;钒酸酐 | ||||||
|
第三部分:危险性概述 |
危险性类别: | 第6.1类 毒害品 |
侵入途径: | 吸入 食入 经皮吸收 |
健康危害: | 对呼吸系统和皮肤有损害作用。急性中毒:可引起鼻、咽、肺部刺激症状,多数工人有咽痒、干咳、胸闷、全身不适、倦怠等表现,部分患者可引起肾炎、肺炎。慢性中毒:长期接触可引起慢性支气管炎、肾损害、视力障碍等。 |
环境危害: | |
燃爆危险: | 本品不燃,高毒。 |
第四部分:急救措施 |
皮肤接触: | 脱去污染的衣着,立即用流动清水彻底冲洗。 |
眼睛接触: | 立即提起眼睑,用流动清水冲洗。 |
吸入: | 脱离现场至空气新鲜处。注意保暖,必要时进行人工呼吸。就医。 |
食入: | 误服者给饮大量温水,催吐,就医。 |
第五部分:消防措施 |
危险特性: | 不燃。与三氟化氯、锂接触剧烈反应。 |
有害燃烧产物: | 可能产生有害的毒性烟雾。 |
灭火方法及灭火剂: | 不燃。火场周围可用的灭火介质。 |
消防员的个体防护: | 消防人员必须穿全身防火防毒服,在上风向灭火。灭火时尽可能将容器从火场移至空旷处。 |
禁止使用的灭火剂: | |
闪点(℃): | 无意义 |
自燃温度(℃): | 无意义 |
爆炸下限[%(V/V)]: | 无意义 |
爆炸上限[%(V/V)]: | 无意义 |
最小点火能(mJ): | |
爆燃点: | |
爆速: | |
最大燃爆压力(MPa): | |
建规火险分级: |
第六部分:泄漏应急处理 |
应急处理: | 隔离泄漏污染区,周围设警告标志,建议应急处理人员戴正压自给式呼吸器,穿化学防护服。不要直接接触泄漏物,避免扬尘,用清洁的铲子收集于干燥净洁有盖的容器中,转移到安全场所。也可以用水泥、沥青或适当的热塑性材料固化处理再废弃。如大量泄漏,收集回收或无害处理后废弃。 |
第七部分:操作处置与储存 |
操作注意事项: | 密闭操作,局部排风。操作人员必须经过专门培训,严格遵守操作规程。建议操作人员佩戴防尘面具(全面罩),穿胶布防毒衣,戴橡胶手套。远离易燃、可燃物。避免产生粉尘。避免与酸类接触。搬运时要轻装轻卸,防止包装及容器损坏。配备泄漏应急处理设备。倒空的容器可能残留有害物。 |
储存注意事项: | 储存于阴凉、通风的库房。远离火种、热源。应与易(可)燃物、酸类、食用化学品分开存放,切忌混储。储区应备有合适的材料收容泄漏物。应严格执行极毒物品“五双”管理制度。 |
第八部分:接触控制/个体防护 |
最高容许浓度: | 中国MAC:0.1mg/m3[烟]苏联MAC:0.1mg/m3[烟]美国TWA:OSHA 0 |
监测方法: | N-肉桂酸-邻-甲苯羟胺分光光度法;N-肉桂酸-邻-甲苯羟胺比色法 |
工程控制: | 密闭操作,局部排风。 |
呼吸系统防护: | 空气中浓度超标时,应该佩带防毒面具。必要时佩带自给式呼吸器。 |
眼睛防护: | 戴化学安全防护眼镜。 |
身体防护: | 穿相应的防护服。 |
手防护: | 戴防护手套。 |
其他防护: | 工作现场禁止吸烟、进食和饮水。工作后,淋浴更衣。单独存放被毒物污染的衣服,洗后再用。进行就业前和定期 |
第九部分:理化特性 |
外观与性状: | 橙黄色或红棕色结晶粉末。 |
pH: | 无资料 |
熔点(℃): | 690 |
沸点(℃): | 分解 |
相对密度(水=1): | 3.35 |
相对蒸气密度(空气=1): | 无资料 |
饱和蒸气压(kPa): | 无资料 |
燃烧热(kJ/mol): | 无意义 |
临界温度(℃): | 分解温度(℃):1750 |
临界压力(MPa): | 无资料 |
辛醇/水分配系数的对数值: | 无资料 |
闪点(℃): | 无意义 |
引燃温度(℃): | 无意义 |
爆炸上限%(V/V): | 无意义 |
爆炸下限%(V/V): | 无意义 |
分子式: | V2O5 |
分子量: | 182 |
蒸发速率: | |
粘性: | |
溶解性: | 微溶于水,不溶于乙醇,溶于浓酸、碱。 |
主要用途: | 广泛用于有机合成工业及硫酸工业中,也用作玻璃搪瓷着色剂,磁性材料。 |
第十部分:稳定性和反应活性 |
稳定性: | 在常温常压下 稳定 |
禁配物: | 强酸、易燃或可燃物。 |
避免接触的条件: | |
聚合危害: | 不能出现 |
分解产物: | 可能产生有害的毒性烟雾。 |
第十一部分:毒理学资料 |
急性毒性: | 属高毒类LD50:10mg/kg(大鼠经口) LC50:无资料 |
急性中毒: | |
慢性中毒: | |
亚急性和慢性毒性: | |
刺激性: | |
致敏性: | |
致突变性: | |
致畸性: | |
致癌性: |
第十二部分:生态学资料 |
生态毒理毒性: | |
生物降解性: | |
非生物降解性: | |
生物富集或生物积累性: |
第十三部分:废弃处置 |
废弃物性质: | |
废弃处置方法: | |
废弃注意事项: |
第十四部分:运输信息 |
|
危险货物编号: | 61028 |
UN编号: | 2862 |
包装标志: | |
包装类别: | Ⅱ |
包装方法: | |
运输注意事项: | 储存于阴凉、通风仓间内。远离火种、热源。防止阳光直射。包装必须密封,切勿受潮。应与碱类、酸类、氧化剂等分开存放。不可混储混运。搬运时要轻装轻卸,防止包装及容器损坏。分装和搬运作业要注意个人防护。 |
RETCS号: | |
IMDG规则页码: |
第十五部分:法规信息 |
国内化学品安全管理法规: | 化学危险物品安全管理条例 (1987年2月17日国务院发布),化学危险物品安全管理条例实施细则 (化劳发[1992] 677号),工作场所安全使用化学品规定 ([1996]劳部发423号)等法规,针对化学危险品的安全使用、生产、储存、运输、装卸等方面均作了相应规定;常用危险化学品的分类及标志 (GB 13690-92)将该物质划为第6.1 类毒害品;剧毒物品分级、分类与品名编号(GA 57-93)中,该物质属第三类 B级无机剧毒品。 |
国际化学品安全管理法规: |
第十六部分:其他信息 |
参考文献: | 1.周国泰,化学危险品安全技术全书,化学工业出版社,1997 2.国家环保局有毒化学品管理办公室、北京化工研究院合编,化学品毒性法规环境数据手册,中国环境科学出版社.1992 3.Canadian Centre for Occupational Health and Safety,CHEMINFO Database.1998 4.Canadian Centre for Occupational Health and Safety, RTECS Database, 1989 |
填表时间: | 年月日 |
填表部门: | |
数据审核单位: | |
修改说明: | |
其他信息: | 1 |
MSDS修改日期: | 年月日 |
分子结构与计算化学数据
分子结构数据
1、摩尔折射率:无可用的
2、摩尔体积(cm3/mol):无可用的
3、等张比容(90.2K):无可用的
4、表面张力(dyne/cm):无可用的
5、介电常数:无可用的
6、极化率(10-24cm3):无可用的
7、单一同位素质量:181.862501 Da
8、标称质量:182 Da
9、平均质量:181.88 Da
计算化学数据
1.疏水参数计算参考值(XlogP):无
2.氢键供体数量:0
3.氢键受体数量:5
4.可旋转化学键数量:0
5.互变异构体数量:无
6.拓扑分子极性表面积77.5
7.重原子数量:7
8.表面电荷:0
9.复杂度:124
10.同位素原子数量:0
11.确定原子立构中心数量:0
12.不确定原子立构中心数量:0
13.确定化学键立构中心数量:0
14.不确定化学键立构中心数量:0
15.共价键单元数量:1